Specifically, our study demonstrated a positive association of Metrnβ with inflammatory mediators like CXCL9, IL10, IL18 and IL1RA, lending further support to the claim that Metrnβ participates in the initiation and progression of pathogenic inflammation in SLE. Here, CXCL9 is linked to systemic lupus erythematosus.